MOMA was established in 2008 at the Science Center Skejby, nearby the hospital.
From March 2018 MOMA is part of and managed by the Department of Clinical Biochemistry at Aarhus University Hospital.
MOMA houses the National Whole Genome Sequencing Center West under the Danish National Genome Center, which will contribute to the development of precision medicine to the benefit of patients by sequencing 60.000 genomes from 2019 to approximately 2023.
You can find more information about the department at moma.auh.dk (Danish) or at https://www.en.auh.dk/departments/department-of-molecular-medicine-moma/ (English).
MOMA's main activities:
Molecular clinical research, mainly in cancer
National WGS CenterWest under the Danish National Genome Center
MOMA is accredited by DANAK/ILAC by the international laboratory standard DS/EN ISO 15189:2013 for medical examination - genetics.
Our staff is counting more than 100 members including six professors, consultants, doctors, molecular biologists, researchers, bioinformaticians, medical technologists and students.
MOMA collaborates with leading laboratories worldwide especially in clinical translational studies.
MOMA has over time expanded its technological facilities currently housing a wide range of state of the art equipment.
Substantial research fundings are received from The Danish Cancer Society, The Innovation Fund Denmark , The Lundbeck Foundation, The Independent Research Fund Danmark, Novo Nordisk Foundation and many other funds.
|NGS Core Center||